-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UHRj1fVauQro52cspH+06rfiGcoVGufoc8wgGArMyj9NLulPLAve6tzGdjxjsOcN ciOjLr3uXk3XG9aymQ5eXQ== 0000875320-08-000032.txt : 20080522 0000875320-08-000032.hdr.sgml : 20080522 20080522093246 ACCESSION NUMBER: 0000875320-08-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080520 FILED AS OF DATE: 20080522 DATE AS OF CHANGE: 20080522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08853467 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-20 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 EVP & CFO Common Stock 2008-05-20 4 S 0 93 27.48 D 85138 D Common Stock 2008-05-20 4 S 0 93 27.59 D 85045 D Common Stock 2008-05-20 4 S 0 186 27.61 D 84859 D Common Stock 2008-05-20 4 S 0 93 27.71 D 84766 D Common Stock 2008-05-20 4 S 0 93 27.47 D 84673 D Common Stock 2008-05-20 4 S 0 93 27.54 D 84580 D Common Stock 2008-05-20 4 S 0 93 27.64 D 84487 D Common Stock 2008-05-20 4 S 0 93 27.66 D 84394 D Common Stock 2008-05-20 4 S 0 93 27.94 D 84301 D Common Stock 3987 I 401(k) Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Kenneth S. Boger, Attorney-In-Fact 2008-05-22 -----END PRIVACY-ENHANCED MESSAGE-----